Filter:
Able AI
What's the best dilution for PI3K p87 in ?
Product Information
55311-1-AP targets PI3K p87 in WB, ELISA applications and shows reactivity with human, mouse samples.
| Tested Reactivity | human, mouse |
| Cited Reactivity | human, mouse |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
Peptide Predict reactive species |
| Full Name | phosphoinositide-3-kinase, regulatory subunit 6 |
| Calculated Molecular Weight | 84 kDa |
| GenBank Accession Number | NM_001010855 |
| Gene Symbol | PIK3R6 |
| Gene ID (NCBI) | 146850 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q5UE93 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
PIK3R6, also named as C17orf38 and p87PIKAP, is a regulatory subunit of the PI3K gamma complex. It acts as an adapter to drive activation of PIK3CG by G beta gamma proteins. This antibody is specific to PIK3R5.
Publications
What published studies show
The PI3K p87 Polyclonal antibody (Cat# 55311-1-AP) has 1 citation. It was used in a Western Blot study published in Neoplasia (2021), investigating how ABCC5 facilitates sorafenib resistance by inhibiting SLC7A11-induced ferroptosis in hepatocellular carcinoma. The research field encompasses cancer biology, drug resistance, and ferroptosis.
| Species | Application | Title |
|---|---|---|
Neoplasia ABCC5 facilitates the acquired resistance of sorafenib through the inhibition of SLC7A11-induced ferroptosis in hepatocellular carcinoma |
